Physician-Guided Protocols

REGENERATIVE
BIOLOGICS

Advanced tissue-derived products processed in FDA-registered laboratories — physician-guided protocols by Dr. Jarrod Wilson

What Are Regenerative Biologics?

Regenerative biologics are products derived from donated human tissue, processed and tested in FDA-registered laboratories. These products contain naturally occurring components such as growth factors, cytokines, extracellular matrix proteins, and extracellular vesicles. At The Remedy IV, all biologic protocols are physician-supervised and require a thorough consultation prior to administration.

Signaling Products

Contain concentrated growth factors and cytokines — naturally occurring proteins involved in cellular communication.

Structural Products

Contain extracellular matrix components — proteins that provide structural scaffolding in tissue environments.

Extracellular Vesicles

Contain nano-scale vesicles with diverse molecular cargo including proteins, lipids, and nucleic acids.

Our Biologic Products

Each product is processed by FDA-registered laboratories and characterized for its compositional profile.

Signaling

Genesis RPA

Regenerative Placental Allograft containing 300+ measurable cytokines and growth factors. Lab-tested compositional profile provides detailed characterization of protein content.

Products interested in: Growth factor-rich signaling profiles
Structural

Nano Flex

Flowable connective tissue matrix containing collagen, hyaluronic acid, and extracellular matrix proteins. Processed to maintain native compositional integrity.

Products interested in: Matrix-based structural composition
Exosomes

Nano Xsomes

Purified extracellular vesicle product with diverse molecular cargo. Processed under strict laboratory protocols to characterize vesicle concentration and content.

Products interested in: Extracellular vesicle composition
Structural

Matrix

Intact tissue scaffold containing native extracellular matrix architecture. Preserves the original structural organization of donated tissue components.

Products interested in: Native tissue scaffold architecture
Signaling

Nano AER

Amniotic-derived product containing a concentrated growth factor profile. Characterized for its signaling molecule content through laboratory analysis.

Products interested in: Amniotic-derived signaling composition
Exosomes

Alocyte

Extracellular vesicle preparation with characterized protein and lipid content. Laboratory analysis provides detailed compositional profiling of vesicle cargo.

Products interested in: Characterized vesicle preparation
Exosomes

Nano EX

Lyophilized umbilical cord-derived exosome product containing 30 billion exosomes with added peptides and growth factors. Shelf-stable formulation requires no refrigeration. Compositional profile includes elastin peptides, collagen peptides, collagen tri-peptide, and a full complement of placental, vascular endothelial, and transforming growth factors.

Products interested in: Lyophilized exosome composition with peptide profile
Signaling

Nano Flow 2.0

Umbilical cord-derived formulation containing 80 million mesenchymal growth factors in a biologically active cellular matrix (2ml). Processed using advanced ultra-filtration to produce a tissue-free growth factor media. Compositional profile includes collagenic growth factors, proteoglycans, regulatory proteins, cytokines, and peptides with characterized immunomodulatory content.

Products interested in: Ultra-filtered umbilical cord-derived growth factor composition
Entry Level

Nano PRP Jelly

Platelet-rich plasma combined with a proprietary carrier matrix. Uses the patient's own blood components, processed on-site to concentrate platelet-derived growth factors.

Products interested in: Autologous platelet-derived products

How It Works

01

Consultation

Comprehensive health assessment and candidacy evaluation with Dr. Wilson to discuss your goals and medical history.

02

Informed Consent

Detailed discussion of the product, the procedure, expected experience, and all relevant disclosures before proceeding.

03

Administration

Physician-guided application of the selected protocol in our clinical setting with ongoing monitoring.

Who Explores Biologics

Our protocols are designed around individual goals, not specific conditions.

People Exploring Joint Comfort Options

People Interested in Scalp & Hair Wellness

People Focused on Wellness & Longevity

People Exploring Musculoskeletal Support

People Interested in Skin Rejuvenation

People Exploring Intimate Wellness

People Considering Sports & Activity Recovery

People Interested in Autoimmune Wellness Support

Why The Remedy IV

Physician-Led Protocols

Every biologic protocol is designed and supervised by Dr. Jarrod Wilson. Your consultation, product selection, and administration are all physician-guided from start to finish.

Products from FDA-Registered Laboratories

All biologic products are sourced from FDA-registered tissue processing laboratories that maintain rigorous quality standards, testing protocols, and regulatory compliance.

Transparent Sourcing & Chain of Custody

Full traceability from tissue donation through processing and delivery. We maintain complete documentation of sourcing, handling, and chain of custody for every product.

Frequently Asked Questions

Regenerative biologics are products derived from donated human tissue that are processed and tested in FDA-registered laboratories. These products contain naturally occurring components — including growth factors, cytokines, extracellular matrix proteins, and extracellular vesicles — that are present in human tissue. Each product is characterized for its compositional profile through laboratory analysis.
No. The biologic products offered at The Remedy IV are not stem cell therapies. These are tissue-derived products that contain growth factors, cytokines, extracellular matrix components, and extracellular vesicles — not live stem cells. The products are processed from donated human tissue by FDA-registered laboratories and are classified as human cells, tissues, and cellular and tissue-based products (HCT/Ps). It is important to understand this distinction when evaluating your options.
The number of sessions varies by individual and is determined during your consultation with Dr. Wilson. Factors such as your health history, goals, and the specific protocol selected all play a role in determining an appropriate plan. There is no standard number of sessions that applies to everyone.
These products have not been approved by the FDA for any specific therapeutic indication. They are processed by FDA-registered laboratories and classified as human cells, tissues, and cellular and tissue-based products (HCT/Ps) under FDA regulation 21 CFR Part 1271. This classification establishes requirements for donor eligibility, processing controls, and record-keeping, but does not constitute FDA approval for therapeutic use.
Most insurance plans do not cover regenerative biologic products. These products are generally considered elective and are not covered by Medicare, Medicaid, or most private insurance plans. During your consultation, our team will provide transparent pricing and discuss any available payment options.
Individual experiences vary significantly. Dr. Wilson will discuss what to expect during your consultation, including the procedure itself, any preparation required, and the post-procedure period. We do not guarantee any specific outcome. Your experience will depend on numerous individual factors that will be evaluated during your consultation.

Interested in Learning More About
Regenerative Biologics?

Mobile concierge services available — we come to you.